CCA
INO icon

Catalyst Capital Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Catalyst Capital Advisors’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,417
Closed -$530K – 574
2015
Q2 		$530K Hold
5,417
– – 0.06% 229
2015
Q1 		$530K Sell
5,417
-24,166
-82% -$2.34M 0.06% 197
2014
Q4 		$3.26M Hold
29,583
– – 0.38% 68
2014
Q3 		$3.5M Buy
+29,583
New +$3.69M 0.45% 68

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Catalyst Capital Advisors's INO Position: Q3 2015 in Review

Catalyst Capital Advisors sold out of Inovio Pharmaceuticals (INO) in Q3 2015, closing a stake of 5,417 shares — an estimated $530K sold.

Catalyst Capital Advisors first reported a position in INO in Q3 2014 and held it in 4 quarters. The position peaked at $3.5M in Q3 2014. 114 funds tracked by Wall St. Rank hold INO as of Q3 2015.

  • Catalyst Capital Advisors reported no remaining Inovio Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Catalyst Capital Advisors sold 5,417 Inovio Pharmaceuticals shares in Q3 2015, an estimated $530K.
  • Catalyst Capital Advisors first reported a position in Inovio Pharmaceuticals in Q3 2014 and held it in 4 quarters.
  • Catalyst Capital Advisors's Inovio Pharmaceuticals position peaked at $3.5M in Q3 2014.
  • 114 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2015.

Based on Catalyst Capital Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.